… and severity of Parkinson's disease. Relevance to Diagnosis/Treatment of Parkinson’s Disease:                 … potential results can also give useful information for diagnosis of early Parkinson's disease and for patient's responsiveness …

… tolerated and results in stable blood levels. Impact on Diagnosis/Treatment of Parkinson’s Disease:  This drug might be used early after the diagnosis of PD to boost the activity of dopamine cells and …

… of the CSF1R-binding compounds we develop. Impact on Diagnosis/Treatment of Parkinson’s disease:  Development of … PET tracer for detecting CSF1R would support diagnosis of PD prior to symptom onset or in early stages. It will also allow the monitoring of changes …

… there is an urgent need to identify biomarkers that can aid early diagnosis and patient enrichment for ongoing and future …

… the blood. We think that inflammation drives the worsening of PD because it increases the production of neurotoxic … called kynurenines. We discovered that a number of these compounds are increased in people with PD, and that their … novel PD biomarkers and to target the kynurenine pathway for potential PD treatment. Hypothesis:  With this study …

… gene Pink1, mutations in which have been associated with early onset PD in humans. About 70% of preclinical models in … and correlate it to the disease progression.  Impact on Diagnosis/Treatment of Parkinson’s … use microbiome tracing as a non-invasive marker for PD diagnosis. Correction of microbiome changes or inflammation …